Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAUL E EMMANS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1033130646
CMS profile
1865
Location
YAKIMA, WA

General Payments · PY2018–2024

$2,765.38

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$408.57

9 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $408.57 9

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $259.70 5
Teva Pharmaceuticals USA, Inc. $135.37 3
Neurocrine BioSciences, Inc. $13.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $718.14 21
PY2019 $513.69 13
PY2020 $62.20 4
PY2021 $300.43 9
PY2022 $318.22 13
PY2023 $444.13 13
PY2024 $408.57 9

Payment records · PY2024 (9)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $105.90 03/14/2024 Food and Beverage Undisputed 01/23/2026 1104376337 CMS
AstraZeneca Pharmaceuticals LP $21.42 05/30/2024 Food and Beverage Undisputed 01/23/2026 1105470855 CMS
AstraZeneca Pharmaceuticals LP $17.39 06/25/2024 Food and Beverage Undisputed 01/23/2026 1105567877 CMS
AstraZeneca Pharmaceuticals LP $99.65 07/10/2024 Food and Beverage Undisputed 01/23/2026 1105513905 CMS
AstraZeneca Pharmaceuticals LP $15.34 10/15/2024 Food and Beverage Undisputed 01/23/2026 1105369358 CMS
Neurocrine Biosciences, Inc. $13.50 06/20/2024 Food and Beverage Undisputed 01/23/2026 1150878595 CMS
Teva Pharmaceuticals USA, Inc. $20.68 04/30/2024 Food and Beverage Undisputed 01/23/2026 1151545031 CMS
Teva Pharmaceuticals USA, Inc. $91.94 06/13/2024 Food and Beverage Undisputed 01/23/2026 1151545073 CMS
Teva Pharmaceuticals USA, Inc. $22.75 07/24/2024 Food and Beverage Undisputed 01/23/2026 1151545077 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.